Register | Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | ESMO 2018 Congress
Targeted Therapies introduces Expert Perspective Virtual Tumor Board, a video editorial series featuring multi-disciplinary collaboration between professionals reviewing patient cases and discussing diagnoses, biomarker testing, and treatment strategies.
Browse by Series:
Case 2: Molecular Risk Stratification in Myeloma
Case 2: Molecular Risk Stratification in Myeloma
Case 2: MRD Negativity in High-Risk Myeloma
Case 2: MRD Negativity in High-Risk Myeloma
Case 2: The Role of Maintenance Therapy in Myeloma
Case 2: The Role of Maintenance Therapy in Myeloma
Case 3: Considerations for Second-Line Therapy in Stage IV NSCLC
Case 3: Considerations for Second-Line Therapy in Stage IV NSCLC
Case 3: Tissue & Plasma Sampling in Stage IV NSCLC
Case 3: Tissue & Plasma Sampling in Stage IV NSCLC
Case 3: Second-Line Therapy After Chemo/I-O in Stage IV NSCLC
Case 3: Second-Line Therapy After Chemo/I-O in Stage IV NSCLC
Case 3: Rapidly Progressing Stage IV NSCLC Following I-O
Case 3: Rapidly Progressing Stage IV NSCLC Following I-O
Case 1: Transplant Eligibility in Myeloma
Case 1: Transplant Eligibility in Myeloma
Case 1: Molecular Testing in Myeloma
Case 1: Molecular Testing in Myeloma
Case 1: Consolidation Therapy in Myeloma
Case 1: Consolidation Therapy in Myeloma
Case 1: Optimal Induction Therapy for Myeloma
Case 1: Optimal Induction Therapy for Myeloma
Case 1: Ineligibility for Transplant in Myeloma
Case 1: Ineligibility for Transplant in Myeloma
<< Prev Page
Next Page >>
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.